Titanium dioxide has also been classified as a possible human carcinogen by the International Agency for Research on Cancer, which has caused concern about its use in food products. This classification, however, is currently based on limited evidence from animal studies that involved the inhalation of titanium dioxide particles that increased the risk of lung cancer.

TiO₂ is also used in oral pharmaceutical formulations, and the Pharmaceutical Excipients handbook considers nano-sized TiO₂ a non-irritant and non-toxic excipient. Despite the fact that TiO₂ submicron- and nano-sized particles are widely used as food and pharmaceutical additives, information on their toxicity and distribution upon oral exposure is very limited.

Titanium IV oxide is also used in the pharmaceutical industry. It is often used as a coating for medications to improve their stability and appearance. Titanium dioxide helps to protect medications from degradation caused by light, moisture, and other environmental factors. It is commonly used in tablets, capsules, and other oral dosage forms to improve their shelf life and effectiveness.